Your browser doesn't support javascript.
Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral Effects.
Kannan, Abhilash; Suomalainen, Maarit; Volle, Romain; Bauer, Michael; Amsler, Marco; Trinh, Hung V; Vavassori, Stefano; Schmid, Jana Pachlopnik; Vilhena, Guilherme; Marín-González, Alberto; Perez, Ruben; Franceschini, Andrea; Mering, Christian von; Hemmi, Silvio; Greber, Urs F.
  • Kannan A; Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.
  • Suomalainen M; Neurimmune AG, Wagistrasse 18, 8952 Schlieren, Switzerland.
  • Volle R; Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.
  • Bauer M; Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.
  • Amsler M; Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.
  • Trinh HV; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.
  • Vavassori S; Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.
  • Schmid JP; Department of Molecular Life Sciences, University of Zürich, 8057 Zürich, Switzerland.
  • Vilhena G; Genezen, 9900 Westpoint Dr, Suite 128, Indianapolis, IN 46256, USA.
  • Marín-González A; Division of Immunology, University Children's Hospital Zürich, 8032 Zürich, Switzerland.
  • Perez R; Division of Immunology, University Children's Hospital Zürich, 8032 Zürich, Switzerland.
  • Franceschini A; Faculty of Medicine, University of Zürich, 8006 Zürich, Switzerland.
  • Mering CV; Departamento de Física Teórica de la Materia Condensada, Universidad Autónoma de Madrid, E-28049 Madrid, Spain.
  • Hemmi S; Condensed Matter Physics Center (IFIMAC), Universidad Autónoma de Madrid, E-28049 Madrid, Spain.
  • Greber UF; Department of Macromolecular Structures, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Cantoblanco, E-28049 Madrid, Spain.
Viruses ; 14(7)2022 06 28.
Article in English | MEDLINE | ID: covidwho-1911660
ABSTRACT
Pathogen-associated molecular patterns, including cytoplasmic DNA and double-strand (ds)RNA trigger the induction of interferon (IFN) and antiviral states protecting cells and organisms from pathogens. Here we discovered that the transfection of human airway cell lines or non-transformed fibroblasts with 24mer dsRNA mimicking the cellular micro-RNA (miR)29b-1* gives strong anti-viral effects against human adenovirus type 5 (AdV-C5), influenza A virus X31 (H3N2), and SARS-CoV-2. These anti-viral effects required blunt-end complementary RNA strands and were not elicited by corresponding single-strand RNAs. dsRNA miR-29b-1* but not randomized miR-29b-1* mimics induced IFN-stimulated gene expression, and downregulated cell adhesion and cell cycle genes, as indicated by transcriptomics and IFN-I responsive Mx1-promoter activity assays. The inhibition of AdV-C5 infection with miR-29b-1* mimic depended on the IFN-alpha receptor 2 (IFNAR2) and the RNA-helicase retinoic acid-inducible gene I (RIG-I) but not cytoplasmic RNA sensors MDA5 and ZNFX1 or MyD88/TRIF adaptors. The antiviral effects of miR29b-1* were independent of a central AUAU-motif inducing dsRNA bending, as mimics with disrupted AUAU-motif were anti-viral in normal but not RIG-I knock-out (KO) or IFNAR2-KO cells. The screening of a library of scrambled short dsRNA sequences identified also anti-viral mimics functioning independently of RIG-I and IFNAR2, thus exemplifying the diverse anti-viral mechanisms of short blunt-end dsRNAs.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferon Type I / MicroRNAs / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: V14071407

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Interferon Type I / MicroRNAs / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: V14071407